References

 

1. American Cancer Society, “Cancer Facts & Figures, 2008”
2. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990; 65: 1104-1110
3. Blum HE. Treatment of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19: 129-145
4. Fong, Y; Blumgart, LH; Cohen, AM.  Surgical Treatment of Colorectal Metastases to the Liver. CA Cancer J Clin 1995; 45: 50-62
5. Tsuzuki T, Sugioka A, Ueda M, Iida S, Kanai T, Yoshii H, Nakayasu K. Hepatic resection for hepatocellular carcinoma. Surgery 1990; 107: 511-520
6. Hawkins MA, Dawson LA Radiation therapy for hepatocellular carcinoma: from palliation to cure. Cancer. 2006 Apr 15;106(8):1653-63.
7. Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007;67:793-798.
8. Wada H, Takai Y, Nemoto K, et al. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004;58:1114-1120.
9. Mendez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, Nuyttens JJ, Brandwijk RP, Verhoef C, Ijzermans JN, Levendag PC. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol 2006;45:831-837.
10. Wong KH, Dieterich S, Tang, J, and Cleary, K. Quantitative Measurement of CyberKnife Robotic Arm Steering. TechnolCancer ResTreat. 2007; 6[6], 589-594.
11. Thomas MB, O'Beirne JP, Furuse J, Chan AT, Abou-Alfa G, Johnson P. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol 2008, 15(4):1008-1014.
12. O'Neil BH, Venook AP. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. Oncologist 2007, 12(12):1425-1432.
13. Thomas MB, O'Beirne JP, Furuse J, Chan AT, Abou-Alfa G, Johnson P..Ann Surg Oncol. 2008 Apr;15(4):1008-14. Epub 2008 Jan 31.